We are live on
!
Find out more
TCM
Towercrest Capital Management Portfolio holdings
AUM
$642M
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.68%
1 Year Est. Return
+11.71%
3 Year Est. Return
+31.42%
5 Year Est. Return
+23.73%
10 Year Est. Return
+78.8%
AUM
$547M
AUM Growth
+$18.9M
(+3.6%)
Cap. Flow
+$1.75M
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
46.25%
Holding
98
New
4
Increased
36
Reduced
21
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$1.1M |
| 2 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$773K |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$734K |
| 4 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$529K |
| 5 |
Schwab U.S Small- Cap ETF
SCHA
|
+$491K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptevo Therapeutics
APVO
|
+$3.26M |
| 2 |
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
|
+$615K |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$466K |
| 4 |
KALA BIO
KALA
|
+$321K |
| 5 |
Moderna
MRNA
|
+$280K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.84% |
| 2 | Communication Services | 0.94% |
| 3 | Financials | 0.49% |
| 4 | Healthcare | 0.44% |
| 5 | Consumer Discretionary | 0.36% |
Similar funds
APC
CFM
RR
GECH
WHGAM
OP
PCM
CRCM
Towercrest Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Towercrest Capital Management held 98 positions worth $547M, up 3.6% from $528M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Towercrest Capital Management's Q4 2021 filing shows 4 new, 36 increased, 21 reduced and 4 closed positions. Its largest new stake was NVIDIA: 7,890 shares worth $232K. The largest sale was Impel Pharmaceuticals Inc. Common Stock, an estimated $615K.
By sector, the portfolio is most concentrated in Technology at 2.8% of assets, up from 2.4% a quarter earlier, followed by Communication Services and Financials.
- Towercrest Capital Management's largest Q4 2021 buy was NVIDIA: 7,890 shares worth $232K.
- Towercrest Capital Management added most to Schwab Emerging Markets Equity ETF in Q4 2021, an estimated $1.1M increase.
- Towercrest Capital Management's biggest Q4 2021 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $466K.
- Towercrest Capital Management fully exited Impel Pharmaceuticals Inc. Common Stock in Q4 2021, selling an estimated $615K.
- Towercrest Capital Management's ten largest holdings make up 46% of its $547M portfolio in Q4 2021.
- Towercrest Capital Management opened 4 new positions and closed 4 in Q4 2021.
- Towercrest Capital Management's portfolio value rose 3.6% quarter-over-quarter to $547M.
Based on Towercrest Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.